Dr. Phulrenu Chauhan

Submitted by contenteditor on Tue, 06/22/2021 - 16:26
  • Guide and Post Graduate teacher for DNB Endocrinology students since 20 years at P.D. Hinduja National Hospital & Medical Research Centre.
  • Member – Maharashtra University of Health Sciences (MUHS) Board of Studies Committee for Medicine and Allied- Superspeciality courses.
  • Teacher for Diploma Dibetology candidates under College of Physicians & Surgeons at Hinduja Healthcare Surgical, Khar, Mumbai.
  • Teacher for Diabetes Diploma Students at Bombay University for 7 years.
  • 8 years of experience as a Postgraduate Teacher for General Medicine at Seth G.S. Medical College & KEM Hospital, Mumbai.
  • Co-guide to student doing Post Graduate Diploma Course in Clinical Nutrition and Dietetics of SVT College of Home Science, SNDT Women's University, Juhu.
  • Teacher for Fellowship in Diabetology at P.D. Hinduja National Hospital & Medical Research Centre, Mahim, Mumbai.
  • Resource Person for ongoing Nursing Education programmes at P.D. Hinduja National Hospital & Medical Research Centre.
Dr profile image for desktop
Phulrenu Chauhan
Dr profile image for mobile
Phulrenu Chauhan
Specialities
First name
Phulrenu
Last name
Chauhan
Designation
Section Head - Endocrinology, Consultant – Endocrinology
Qualifications
DM (Endocrinology), M.D. (General Medicine), M.B.B.S
Areas of expertise
Paediatric and Adolescent Endocrinology, Thyroid cancers, thyroid nodules/ enlargement, Other thyroid diseases, Hirsutism, Acne, Polycystic Ovarian Disease, Parathyroid and Calcium Disorders, Vitamin D deficiency, Perimenopausal management, Pitutary diseases, Metabolic Bone Diseases and Osteoporosis, Nutrition, Obesity, Type-1 Diabetes Mellitus.
Professional Affiliations
  • Association of Physician of India
  • Endocrine Society of India
  • Maha Endocrine Society
  • Endocrine Society (USA)
  • Indian Academy of Paediatrics
  • Menopause Society of India
  • Indian Society for Paediatric and Adolescent Endocrinology
  • Indian Society of Bone Metabolism and Research
Research Experience

As Principal Investigator:

  • A Multicenter, Double-Blind Study to Determine the Efficacy and Safety of SYR-322 plus Pioglitazone HCl, (Actos ®), SYR-322 Alone or Pioglitazone HCl Alone in Subjects with Type 2 Diabetes.
  • "Open non-comparative, multi-centre study to determine the efficacy and safety of Rimonabant in overweight or obese subjects".
  • A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus.- 2017.
  • Ongoing- Multicentric T1D1 study at P. D. Hinduja National Hospital and M.R.C., Mumbai.

 

As Co-Investigator:

  • A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination with Metformin IR or Metformin XR in Pediatric Patients with Type 2 Diabetes who have Inadequate Glycemic Control.- 2006
  • Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents with Type 2 Diabetes.- 2009
  • Randomized, placebo controlled clinical trial to assess the safety and efficacy of Odanacatib (Mk-0822) to reduce the fracture in osteoporotic postmenopausal women treated with Vitamin D and Calcium.- 2009
  • Registry of People with Diabetes in India with Young Age at Onset.- 2012
  • Effect of liraglutide or glimepiride added to metformin on blood glucose control in subjects with type 2 diabetes.- 2013
  • Control on Metformin Alone.A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to LANTUS® in Adult Patients with Type 2 Diabetes Mellitus: the Element 5 Study.- 2019
  • A 24 week Prospective Non-Interventional Post-Marketing Surveillance Study on Adverse Events and Serious Adverse Events in Patients with Type 2 Diabetes Mellitus in India being started on Dulaglutide (Trulicity™)- 2018
  • “A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (≥10 to 18 years) with Type 2 Diabetes Mellitus.- 2018
  • Semaglutide outcome trial in cardivascular events.- 2019
  • A registry for secondary fracture prevention service, implemented by healthcare systems for the treatment of Osteoporotic patients.- 2019
  • Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Prandial Technosphere® Insulin Inhalation Powder Versus Placebo Inhalation Powder in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Oral Antidiabetic Drugs Over a 24-week Treatment Period. – 2020
Publications
  • Numerous publications in indexed and peer-reviewed national and international journals.
  • Chapters in textbooks, clinical books of Diabetes, Reproductive Endocrinology and General Medicine.
Dr profile image for List
Phulrenu Chauhan
Head Of Department
On
Doctor Code
CPH
Not Avail Online Booking
Off
Breadcrumb Component
Title
Phulrenu Chauhan
Doc Weight WRT Speciality
Weight
1
Speciality
Salutation
Dr.
Search Keywords

Diabetes